Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by tylerreddickon Apr 05, 2024 12:46pm
106 Views
Post# 35973157

RE:RE:What a fail....

RE:RE:What a fail....
forhandlaren wrote: Simply put - Howard choose to stay as CEO instead of handing over to whoever and thereby close the private placement as planned.

The only way to justify this is by an impressive NR round the corner that provide cash.


That is nonsense. SBM can't afford a new CEO, who would demand a bigger paycheck, and likely wouldn't invest any of his own money in the stock, just take freebies.

So say what you want, Howie is the only CEO we can afford right now, and he has been investing some of his own cash in the company. Yes, I would have liked to see him participate in this financing, but he was already in the process of lending SBM a million bucks, so no one should be surprised he didn't buy into the PP. I am not.

Yes, it will be a tough slog going forward if the AbbVie jerks keep doing nothing, and we will need more operating cash. But the finish line is in sight, so anyone who has been here for any length of time may as well hold on a little longer.
<< Previous
Bullboard Posts
Next >>